Click on there images to view there full Bios
2022 AAADV-ASCO-CDDF Program Committee
Richard L. Schilsky, MD, FACP, FSCT, FASCO
Professor emeritus, University of Chicago
Renzo Canetta, M.D.
Independent Consultant, Former Head of Clinical Cancer Research, and Head of Regulatory Oncology Research Policy, Bristol Myers Squibb
Thomas Fleming, PhD
Professor Statistics, University of Washington
Julie R. Gralow, MD, FACP, FASCO
Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Jaap Verweij, MD, PhD
Managing Director, Cancer Drug Development Forum
Agnes Saint-Raymond
Former EMA Head of the International Affairs Division
H. Kim Lyerly, MD, FACS, FSSO
George Barth Gellar Chair, Professor Surgery, Pathology and Immunology, Duke University
Donald R. Harvey III, PharmD
Professor of Medical Oncology and Pharmacology, Emory University
2022 Pre-Workshop and In-Depth Discussion Group Program Committee
Martin Stockler, MD
Professor of Oncology and Clinical Epidemiology, University of Sydney, Oncology Director at the NHMRC Clinical Trials Centre, University of Sydney
Chitkala Kalidas, PhD
Vice President and Head of Global Regulatory Affairs for Oncology and In Vitro Diagnostics, Bayer
Jian Wang, PhD
Head of Translational, Oncology Regulatory Science, Strategy & Excellence, AstraZeneca
H. Kim Lyerly, MD, FACS, FSSO
George Barth Gellar Chair, Professor Surgery, Pathology and Immunology, Duke University
Terrell Baptiste, MBA
Associate Director, Regulatory Policy and Intelligence, Gilead
Wendy Clemens, PhD
Vice President Early Development Vice President Early Development , Bristol-Myers Squibb